Evidence map›Paper›PMID 33853378›Full record

ArticlePsychiatric services (Washington, D.C.)2021

Addiction Medicine Practice-Based Research Network (AMNet): Building Partnerships.

Robert P Schwartz, Debbie Gibson, Anna Pagano, Amy Goldstein, Adila Ibrahim, Benjamin Doty, Sejal Patel, Frank J Vocci, Diana E Clarke

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Psychiatric services (Washington, D.C.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Robert P SchwartzFriends Research Institute, Baltimore (Schwartz, Ibrahim, Vocci); American Psychiatric Association, Washington, D.C. (Gibson, Doty, Patel, Clarke); American Society of Addiction Medicine, Rockville, MD (Pagano); National Institute on Drug Abuse (NIDA), Rockville, MD (Goldstein). Debra A. Pinals, M.D., Enrico G. Castillo, M.D., M.S.H.P.M., and Ayorkor Gaba, Psy.D., are editors of this column.
Debbie GibsonFriends Research Institute, Baltimore (Schwartz, Ibrahim, Vocci); American Psychiatric Association, Washington, D.C. (Gibson, Doty, Patel, Clarke); American Society of Addiction Medicine, Rockville, MD (Pagano); National Institute on Drug Abuse (NIDA), Rockville, MD (Goldstein). Debra A. Pinals, M.D., Enrico G. Castillo, M.D., M.S.H.P.M., and Ayorkor Gaba, Psy.D., are editors of this column.
Anna PaganoFriends Research Institute, Baltimore (Schwartz, Ibrahim, Vocci); American Psychiatric Association, Washington, D.C. (Gibson, Doty, Patel, Clarke); American Society of Addiction Medicine, Rockville, MD (Pagano); National Institute on Drug Abuse (NIDA), Rockville, MD (Goldstein). Debra A. Pinals, M.D., Enrico G. Castillo, M.D., M.S.H.P.M., and Ayorkor Gaba, Psy.D., are editors of this column.
Amy GoldsteinFriends Research Institute, Baltimore (Schwartz, Ibrahim, Vocci); American Psychiatric Association, Washington, D.C. (Gibson, Doty, Patel, Clarke); American Society of Addiction Medicine, Rockville, MD (Pagano); National Institute on Drug Abuse (NIDA), Rockville, MD (Goldstein). Debra A. Pinals, M.D., Enrico G. Castillo, M.D., M.S.H.P.M., and Ayorkor Gaba, Psy.D., are editors of this column.
Adila IbrahimFriends Research Institute, Baltimore (Schwartz, Ibrahim, Vocci); American Psychiatric Association, Washington, D.C. (Gibson, Doty, Patel, Clarke); American Society of Addiction Medicine, Rockville, MD (Pagano); National Institute on Drug Abuse (NIDA), Rockville, MD (Goldstein). Debra A. Pinals, M.D., Enrico G. Castillo, M.D., M.S.H.P.M., and Ayorkor Gaba, Psy.D., are editors of this column.
Benjamin DotyFriends Research Institute, Baltimore (Schwartz, Ibrahim, Vocci); American Psychiatric Association, Washington, D.C. (Gibson, Doty, Patel, Clarke); American Society of Addiction Medicine, Rockville, MD (Pagano); National Institute on Drug Abuse (NIDA), Rockville, MD (Goldstein). Debra A. Pinals, M.D., Enrico G. Castillo, M.D., M.S.H.P.M., and Ayorkor Gaba, Psy.D., are editors of this column.
Sejal PatelFriends Research Institute, Baltimore (Schwartz, Ibrahim, Vocci); American Psychiatric Association, Washington, D.C. (Gibson, Doty, Patel, Clarke); American Society of Addiction Medicine, Rockville, MD (Pagano); National Institute on Drug Abuse (NIDA), Rockville, MD (Goldstein). Debra A. Pinals, M.D., Enrico G. Castillo, M.D., M.S.H.P.M., and Ayorkor Gaba, Psy.D., are editors of this column.
Frank J VocciFriends Research Institute, Baltimore (Schwartz, Ibrahim, Vocci); American Psychiatric Association, Washington, D.C. (Gibson, Doty, Patel, Clarke); American Society of Addiction Medicine, Rockville, MD (Pagano); National Institute on Drug Abuse (NIDA), Rockville, MD (Goldstein). Debra A. Pinals, M.D., Enrico G. Castillo, M.D., M.S.H.P.M., and Ayorkor Gaba, Psy.D., are editors of this column.
Diana E ClarkeFriends Research Institute, Baltimore (Schwartz, Ibrahim, Vocci); American Psychiatric Association, Washington, D.C. (Gibson, Doty, Patel, Clarke); American Society of Addiction Medicine, Rockville, MD (Pagano); National Institute on Drug Abuse (NIDA), Rockville, MD (Goldstein). Debra A. Pinals, M.D., Enrico G. Castillo, M.D., M.S.H.P.M., and Ayorkor Gaba, Psy.D., are editors of this column.

Funding

Facilitating the Implementation of Interim Methadone to Increase Treatment Access: A Multi-Site Implementation TrialU01DA046910 · NIDA · FRIENDS RESEARCH INSTITUTE, INC. · PI SCHWARTZ, ROBERT P · 2018 to 2021
$4.8M
NIDA NIH HHS U01 DA046910
6 · The paper itself

Abstract

This column describes the collaboration among the American Psychiatric Association (APA), American Society of Addiction Medicine, Friends Research Institute, and the National Institute on Drug Abuse to create the Addiction Medicine Practice-Based Research Network (AMNet). The collaboration, which aims to address the opioid overdose epidemic in the United States, leverages the APA's clinical data registry (PsychPRO) and is recruiting office-based addiction medicine and addiction psychiatry practices for AMNet. AMNet aims to address knowledge gaps regarding patient care in such practices, facilitate performance improvement efforts, and serve as a research platform.

Indexed as

Addiction MedicineOpioid-Related DisordersHumansUnited StatesAlcohol and drug abuseOpioid Use DisorderPractice-based Research NetworkQuality ImprovementQuality of Care

Identifiers

PMID33853378
PMCPMC8249311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.